<DOC>
	<DOCNO>NCT02317705</DOCNO>
	<brief_summary>This study do : - test safety OTL38 - see OTL38 help light cancer view special camera system - test safety special camera system use along OTL38 surgery</brief_summary>
	<brief_title>Phase 2 Study OTL38 Intra-operative Imaging Folate Receptor-alpha Positive Ovarian Cancer</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>1 . Female patient 18 year age old 2 . Have primary diagnosis , high clinical suspicion , primary ovarian cancer ( epithelial type ) , plan primary debulking interval debulking surgery , : Who schedule undergo laparotomy debulking surgery OR Who schedule undergo laparoscopy preauthorized undergo laparotomy debulking surgery , cancer detect laparoscopy 3 . A negative serum pregnancy test Screening follow negative urine pregnancy test day surgery day admission female patient childbearing potential 4 . Female patient childbearing potential less 2 year postmenopausal agree use acceptable form contraception time sign informed consent 30 day study completion 5 . Ability understand requirement study , provide write informed consent authorization use disclosure protect health information , agree abide study restriction return require assessment 1 . Previous exposure OTL38 2 . Known FR alphanegative ovarian cancer 3 . Planned surgical approach via laparoscopy robotic surgery 4 . Any medical condition opinion investigator could potentially jeopardize safety patient 5 . History anaphylactic reaction severe allergy 6 . History allergy component OTL38 , include folic acid 7 . Pregnancy , positive pregnancy test 8 . Clinically significant abnormality electrocardiogram ( ECG ) 9 . Presence psychological , familial , sociological geographical condition potentially hamper compliance study protocol followup schedule 10 . Impaired renal function define eGFR &lt; 50 mL/min/1.73m2 11 . Impaired liver function define value &gt; 3x upper limit normal ( ULN ) alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) , alkaline phosphatase ( ALP ) , total bilirubin . 12 . Known Stage IV ovarian cancer Brain Metastases 13 . Received investigational agent another investigational drug vaccine trial within 30 day prior surgery 14 . Known sensitivity fluorescent light</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>